Reply to: Room for methodological improvement in gait speed study for COPD patients
- PMID: 34413149
- DOI: 10.1183/13993003.01796-2021
Reply to: Room for methodological improvement in gait speed study for COPD patients
Conflict of interest statement
Conflict of interest: J.A. Walsh has nothing to disclose. Conflict of interest: R.E. Barker has nothing to disclose. Conflict of interest: S.S.C. Kon has nothing to disclose. Conflict of interest: S.E. Jones has nothing to disclose. Conflict of interest: W. Banya has nothing to disclose. Conflict of interest: C.M. Nolan reports personal fees from Novartis, outside the submitted work. Conflict of interest: S. Patel has nothing to disclose. Conflict of interest: O. Polgar has nothing to disclose. Conflict of interest: B.M. Haselden has nothing to disclose. Conflict of interest: M.I. Polkey reports personal fees for consultancy from Philips and JFD, grants from GSK, outside the submitted work. Conflict of interest: P. Cullinan has nothing to disclose. Conflict of interest: W.D-C. Man reports grants from Medical Research Council UK, during the conduct of the study; grants from National Institute for Health Research, British Lung Foundation and Pfizer, personal fees from Jazz Pharmaceuticals, Mundipharma and Novartis, non-financial support from GSK, outside the submitted work.
Comment on
-
Gait speed and adverse outcomes following hospitalised exacerbation of COPD.Eur Respir J. 2021 Nov 11;58(5):2004047. doi: 10.1183/13993003.04047-2020. Print 2021 Nov. Eur Respir J. 2021. PMID: 33926974
-
Room for methodological improvement in gait speed study for COPD patients.Eur Respir J. 2021 Dec 2;58(6):2101445. doi: 10.1183/13993003.01445-2021. Print 2021 Dec. Eur Respir J. 2021. PMID: 34413150 No abstract available.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical